105 related articles for article (PubMed ID: 11237432)
21. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
22. The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production.
Volmar CH; Ait-Ghezala G; Frieling J; Paris D; Mullan MJ
Cytokine; 2008 Jun; 42(3):336-44. PubMed ID: 18434187
[TBL] [Abstract][Full Text] [Related]
23. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit.
D'Andrea RJ; Gonda TJ
Exp Hematol; 2000 Mar; 28(3):231-43. PubMed ID: 10720688
[TBL] [Abstract][Full Text] [Related]
24. A low-affinity human granulocyte-macrophage colony-stimulating factor/murine erythropoietin hybrid receptor functions in murine cell lines.
Jubinsky PT; Nathan DG; Wilson DJ; Sieff CA
Blood; 1993 Feb; 81(3):587-91. PubMed ID: 8427955
[TBL] [Abstract][Full Text] [Related]
25. A chimeric protein induces tumor cell apoptosis by delivering the human Bcl-2 family BH3-only protein Bad.
Antignani A; Youle RJ
Biochemistry; 2005 Mar; 44(10):4074-82. PubMed ID: 15751984
[TBL] [Abstract][Full Text] [Related]
26. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
27. Modulation of growth factor receptor function by isoform heterodimerization.
Chang WP; Clevenger CV
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5947-52. PubMed ID: 8650199
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
[TBL] [Abstract][Full Text] [Related]
29. Myeloproliferative disorder and leukaemia in mice induced by different classes of constitutive mutants of the human IL-3/IL-5/GM-CSF receptor common beta subunit.
McCormack MP; Gonda TJ
Oncogene; 1999 Dec; 18(51):7190-9. PubMed ID: 10602472
[TBL] [Abstract][Full Text] [Related]
30. GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells.
Mathew M; Zaineb KC; Verma RS
Apoptosis; 2013 Jul; 18(7):882-95. PubMed ID: 23529188
[TBL] [Abstract][Full Text] [Related]
31. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
33. Regulation of myeloid development and function by colony stimulating factors.
Barreda DR; Hanington PC; Belosevic M
Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
[TBL] [Abstract][Full Text] [Related]
34. A filtration-based assay to quantitate granulocyte-macrophage colony-stimulating factor binding.
Scott CW; Gomes BC; Hubbs SJ; Koenigbauer HC
Anal Biochem; 1995 Jun; 228(1):150-4. PubMed ID: 8572271
[TBL] [Abstract][Full Text] [Related]
35. Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.
Heinzelman P; Priebe MC
Biotechnol Prog; 2015; 31(3):668-77. PubMed ID: 25737095
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
37. A cell type-specific constitutive point mutant of the common beta-subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5 receptors requires the GM-CSF receptor alpha-subunit for activation.
Jenkins BJ; Le F; Gonda TJ
J Biol Chem; 1999 Mar; 274(13):8669-77. PubMed ID: 10085105
[TBL] [Abstract][Full Text] [Related]
38. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor.
Yuan X; Cong Y; Hao J; Shan Y; Zhao Z; Wang S; Chen J
J Mol Biol; 2004 May; 339(1):131-44. PubMed ID: 15123426
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil function and cytokine-specific signaling in chronic neutrophilic leukemia.
Uemura Y; Taguchi T; Kubota T; Saito T; Bandobashi K; Yokoyama A
Int J Lab Hematol; 2009 Feb; 31(1):36-47. PubMed ID: 18241214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
